Daniel Salvadori Net Worth

The estimated Net Worth of Daniel Gesua Sive Salvadori is at least $20 Million dollars as of 26 June 2019. Mr. Salvadori owns over 71,000 units of Abbott Laboratories stock worth over $13,975,244 and over the last 5 years he sold ABT stock worth over $1,891,358. In addition, he makes $4,088,490 as Senior Vice President – Established Pharmaceuticals and Latin America. at Abbott Laboratories.

Mr. Salvadori ABT stock SEC Form 4 insider trading

Daniel has made over 15 trades of the Abbott Laboratories stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 71,000 units of ABT stock worth $2,726,400 on 26 June 2019.

The largest trade he’s ever made was exercising 96,603 units of Abbott Laboratories stock on 23 October 2017 worth over $4,204,163. On average, Daniel trades about 14,294 units every 55 days since 2014. As of 26 June 2019 he still owns at least 167,148 units of Abbott Laboratories stock.

You can see the complete history of Mr. Salvadori stock trades at the bottom of the page.

Daniel Salvadori biography

Daniel Gesua Sive Salvadori is Senior Vice President – Established Pharmaceuticals, Latin America of the Company. From 2013 to 2014 — Chief Executive Officer, Latin America, CFR Pharmaceuticals S.A. (a Latin American pharmaceutical company). From 2012 to 2013 — Executive President, Complex Therapeutics Division, CFR Pharmaceuticals S.A. From 2010 to 2012 — Head of Sales and Marketing, Latin America, Sandoz Pharmaceuticals, Novartis AG (a Swiss multinational pharmaceutical company). From 2009 to 2010 — Director of Global Strategy and Mergers and Acquisitions, Sandoz Pharmaceuticals, Novartis AG.

What is the salary of Daniel Salvadori?

As the Senior Vice President – Established Pharmaceuticals and Latin America. of Abbott Laboratories, the total compensation of Daniel Salvadori at Abbott Laboratories is $4,088,490. There are 4 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $24,254,200.

How old is Daniel Salvadori?

Daniel Salvadori is 40, he’s been the Senior Vice President – Established Pharmaceuticals and Latin America. of Abbott Laboratories since 2014. There are 17 older and no younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 74, who is the Independent Director.

What’s Daniel Salvadori’s mailing address?

Daniel’s mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064-6400.

Insider trading at Abbott Laboratories

Over the last 19 years, insiders at Abbott Laboratories have traded over $300,124,202 worth of Abbott Laboratories stock and bought 1,026,437 units worth $44,673,718 . The most active insider traders include Miles D White, Richard A Gonzalez, and Glenn F Tilton. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,036,946. The most recent stock trade was executed by Randel William Woodgrift on 23 October 2019, trading 21,000 units of ABT stock currently worth $1,691,340.

What does Abbott Laboratories do?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

What does Abbott Laboratories’s logo look like?

Complete history of Mr. Salvadori stock trades at Abbott Laboratories

Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include:

Miles White, Chairman of the Board, Chief Executive Officer
Robert Ford, President, Chief Operating Officer
Brian Yoor, Chief Financial Officer, Executive Vice President – Finance
Hubert Allen, Executive Vice President, General Counsel, Secretary
Daniel Salvadori, Senior Vice President – Established Pharmaceuticals, Latin America.
Robert Alpern, Independent Director
Sally Blount, Independent Director
Glenn Tilton, Independent Director
Samuel Scott, Independent Director
William Osborn, Lead Independent Director
Roxanne Austin, Independent Director
Edward Liddy, Independent Director
Nancy McKinstry, Independent Director
Phebe Novakovic, Independent Director
John Stratton, Independent Director
Daniel Starks, Independent Director
Michelle Kumbier, Independent Director
Darren McDew, Director
Jaime Contreras, Senior Vice President – Core Laboratory Diagnostics, Commercial Operations
Jared Watkin, Senior Vice President
Andrew H Lane, Senior Vice President
Robert E Funck, Senior Vice President
Sean Shrimpton, Senior Vice President
John M Capek, Executive Vice President
Deepak S. Nath, Senior Vice President
Joseph J Manning, Senior Vice President
Roger Bird, Senior Vice President
Brian J Blaser, Senior Vice President
Stephen R Fussell, Senior Vice President
Michael J Warmuth, Senior Vice President
Eric S Fain, Senior Vice President
Lisa D Earnhardt, Executive Vice President
Sharon J Bracken, Senior Vice President
Michael T Rousseau, Pres., Cardiovasc. & Neuromod.
Charles Brynelsen, Senior Vice President
Michael J Pederson, Senior Vice President
Alejandro D Wellisch, Senior Vice President
Sammy Karam, Senior Vice President
Randel William Woodgrift, Senior Vice President
Christopher J Scoggins, Senior Vice President
Richard W Ashley, Executive Vice President
Andrea F Wainer, Executive Vice President
John F Ginascol, Executive Vice President
Jean Yves Pavee, Senior Vice President
W James Farrell, Director
Thomas C Freyman, Senior Vice President
Georges H. De Vos, Senior Vice President
Katherine C. Doyle, Senior Vice President
J. Scott White, Senior Vice President
Charles D Foltz, Senior Vice President
Murthy V Simhambhatla, Senior Vice President
Thomas G Frinzi, Senior Vice President
John C Landgraf, Senior Vice President
Greg W Linder, Vice President
Heather L Mason, Senior Vice President
Paul K Magill, Senior Vice President
A. David Forrest, Senior Vice President
H Laurance Fuller, Director
Carlos Alban, Senior Vice President
James V Mazzo, Senior Vice President
Holger A Liepmann, Senior Vice President
William D Smithburg, Director
Laura J Schumacher, Senior Vice President
David Owen, Director
Edward L Michael, Senior Vice President
Richard A Gonzalez, Chief Operating Officer
Donald V Jr Patton, Senior Vice President
William M Daley, Director
Robert B Hance, Senior Vice President
Mary T Szela, Senior Vice President
Roy S Roberts, Director
Corlis D Murray, Senior Vice President
Thomas F Chen, Senior Vice President
Olivier Bohuon, Senior Vice President
James L Tyree, Senior Vice President
W Ann Reynolds, Director
Boone Jr Powell, Director
Mary K Moreland, Executive Vice President
Edward J Fiorentino, Senior Vice President
Gary E Mccullough, Senior Vice President
Jeffrey M Leiden, President & COO
Jack M Greenberg, Director
Joseph M Nemmers, Senior Vice President
John R Walter, Director
Jeffrey R Binder, Senior Vice President
William G Dempsey, Senior Vice President
A Barry Rand, Director
Thomas M Wascoe, Senior Vice President
Christopher B Begley, Senior Vice President
Lance B Wyatt, Senior Vice President
Guillermo A Herrera, Senior Vice President
Lasa Jose M De, Senior Vice President

Daniel Salvadori Net Worth